SLC10A1 and infection: Some bile salts, including CDCA, are capable of inhibiting sodium taurocholate co-transporting polypeptide (NTCP)-mediated hepatitis B virus (HBV) and hepatitis D virus (HDV) infection, since NTCP serves as a cellular receptor for the entry of these viruses.